Figure 2.
Landmark analysis (after cycle 18) of PFS. PFS differences between positive and negative patients by (A) MS, (B) NGS at the 10–5 threshold, and (C) MFC. Not all patients included in this analysis had the BM MRD testing results available, hence the lower numbers of cases presented in panels B and C.